Nestle infant formula antitrust suit ends with jury verdict for Abbott and AAP.
This article was originally published in The Tan Sheet
Executive Summary
NESTLE INFANT FORMULA ANTI-TRUST CHARGES AGAINST ABBOTT AND AAP DISMISSED by a jury in Los Angeles federal court on June 20. The jury found in favor of defendants Abbott Laboratories and the American Academy of Pediatrics, both charged by Nestle with conspiring to prevent the Swiss company from entering the U.S. infant formula market in the late 1980s. Nestle has marketed the Carnation line of infant formulas since 1988.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning